Come up with a name for your new list and we'll add to it:
Phagenesis raised a round of funding on May 22, 2013. Investors include
Inventages Venture Capital.
Phagenesis has developed a clinically proven treatment for dysphagia, a debilitating and often lethal condition in which the patient's ability to swallow is damaged. Dysphagia can lead to the inhalati…